Year-over-year earnings per share growth for the last twelve months: Theriva Biologics, Inc. (TOVX)

therivabio.com (TOVX) - corporate logo

Theriva Biologics, Inc. (TOVX) maintains a strong authority within the oncology environment based on the development of targeted viruses. The quarterly EPS growth rate confirms financial stability, while the value of 93.00 serves as the current metric indicator. Development relies on robotic laboratories to scale therapy and robust scientific potential in protein inhibition to combat gastrointestinal tumors.

Theriva Biologics Inc (TOVX) Year-over-year net earnings per share growth for the last 12 months: for the period 04/28/2023 - 11/18/2026

Comprehensive metric breakdowns and analytics for therivabio.com (TOVX)

- share price and expert price forecast:
Comprehensive company analysis:Theriva Biologics Inc, TOVX
Manufactured product of Theriva Biologics, Inc.

The implementation of robotic bioreactors to eliminate human error in virus cultivation directly impacts the operational efficiency and future profitability of Theriva Biologics, Inc. (TOVX). The dynamics of quarterly EPS variation measure the rate of change in net income per share, allowing investors to assess the issuer's fundamental stability and the accuracy of financial disclosures through daily monitoring of deviations.

Competitors of Theriva Biologics, Inc.

IBRX: Quarterly EPS earnings growth|IMCR - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months januxrx.com|Year-over-year net earnings per share growth for the last 12 months arcusbio.com (RCUS)|Year-over-year earnings per share growth for the last twelve months Zymeworks Inc (ZYME)|Year-over-year net earnings per share growth for the last 12 months Tango Pharma TNGX|Iovance Biotherapeutics Inc - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Immatics Biotechnologies IMTX|XNCR - Year-over-year earnings per share growth for the last twelve months|CMPX (compasstherapeutics.com) - Year-over-year earnings per share growth for the last 12 months|Replimune Inc. (REPL) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Lyell Immunopharma Inc (LYEL)|Year-over-year net earnings per share growth for the last 12 months IPHA|PYXS - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months CGEN (Compugen Ltd.)|Year-over-year earnings per share growth rate for the last twelve months IOBT|Quarterly EPS earnings growth STRO (Sutro Biopharma)|Year-over-year earnings per one share growth for the last 12 months INKT|Werewolf - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Immix Biopharma|ALX Oncology (ALXO) - Year-over-year earnings per share growth for the last twelve months|cuebiopharma.com (CUE) - Quarterly EPS earnings growth|PDSB (PDS Biotechnology Corp) - Quarterly EPS earnings growth|Quarterly EPS earnings growth sonnetbio.com|Year-over-year earnings per share growth for the last twelve months MAIA Biotechnology, Inc. (MAIA)|LIMN: Year-over-year net earnings per share trend for the last twelve months|LAVA Therapeutics - Year-over-year net earnings per share growth for the last 12 months|nextcure.com (NXTC) - Earnings per share growth in annualized terms for the last twelve months|LPTX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Intensity Therapeutics, Inc. INTS|SNSE: Quarterly EPS earnings growth|Gritstone bio Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KA|Year-over-year earnings per share growth for the last 12 months NEXI (NexImmune, Inc.)|Year-over-year earnings per share growth for the last twelve months Turnstone Biologics Corporation (TSBX)|Year-over-year net earnings per share growth for the last 12 months Vaccinex VCNX|Year-over-year earnings per share growth for the last twelve months harpoontx.com HARP